Pro
Lisa M. Eubanks, PhD, Staff Scientist at the Scripps Research Institute and the Skaggs Institute for Chemical Biology, et al. stated in an Aug. 9, 2006 article titled "A Molecular Link Between the Active Component of Marijuana and Alzheimer's Disease Pathology," published in Molecular Pharmaceutics:
“In contrast to previous studies aimed at utilizing cannabinoids in Alzheimer’s disease therapy, our results provide a mechanism whereby the THC molecule can directly impact Alzheimer’s disease pathology…
It is noteworthy that THC is a considerably more effective inhibitor… than the approved drugs for Alzheimer’s disease treatment, donepezil and tacrine, which reduced [protein deposits in the brain] by only 22% and 7%, respectively, at twice the concentration used in our studies…
THC and its analogues may provide an improved therapeutic for Alzheimer’s disease [by] simultaneously treating both the symptoms and progression of Alzheimer’s disease.”
Aug. 9, 2006 - A Molecular Link Between the Active Component of Marijuana and Alzheimer’s Disease Pathology